Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Takeda signs MoU with BIRAC to support healthcare start-ups
Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a $300 billion…
Lex Witness to host 9th Annual Pharma Legal & Compliance Summit 2023 in Mumbai
The summit is scheduled for December 8, 2023 at the Courtyard by Marriott, Mumbai, Andheri East
Industry and academia should work together to combine discovery biology and translational research
Prof Arun Kumar Shukla, Professor and Sonu Agrawal Memorial Chair, Biological Sciences and Bioengineering, Indian Institute of…
Non-stimulants face uphill battle to penetrate ADHD market despite lower abuse potential: GlobalData
A better alternative strategy to penetrate the saturated ADHD market would be to target key unmet needs in ADHD treatment such as…
AbbVie’s $10.1 bn Immunogen deal fortifies oncology portfolio, signals big pharma’s ADC…
Earlier this year, Pfizer acquired ADC giant Seagen for $43 billion in one of the largest M&A deals in industry history
Mumbai to host IDMA’s flagship event, Pharma Live Expo & Summit in Jan 2024
Set to host more than 500 exhibitors and showcase above 20,000 products
Syngene concludes acquisition of biologics facility from Stelis Biopharma
The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US
Turqoz Tablets USP 0.3 mg/0.03 mg is a contraceptive drug indicated to prevent pregnancy
We are committed to delivering excellence across the pharma supply chain
Rajesh Vedak, MD, Körber India speaks about his company's innovative solutions, strategies to maintain its technological…
Zydus gets US FDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable,…
Pharma contract manufacturing sees historic surge amidst inflation and investment challenges:…
The total commercial dose contract manufacturing organisation (CMO) contract revenue year-on-year (YoY) soared by an impressive…
Karuna Therapeutics’ NDA for KarXT accepted by USFDA
If approved, KarXT would represent the first new pharmacological approach to treating schizophrenia in several decades
ACG showcases concept of next generation capsule filling machine at CPHI and PMEC 2023
ACG’s latest capsule filling machine is a customer-centric concept design, developed in ACG’s German R&D facility, that…
Aurobindo Pharma gets USFDA nod for HIV drug
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Darunavir…
10th edition of India Pharma Awards at CPHI celebrates a decade of excellence and innovation in…
The selection process was guided by EY and evaluated by a distinguished jury, including a Preliminary Online Jury meet and…
16th CPHI & PMEC India 2023 redefines pharma landscape
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors…
Doceree introduces AI-powered Insights for pharma marketers
Doceree Insights is available for healthcare marketers across the globe
AMR poses an immediate and widespread threat to global public health: Experts
Over-the-counter accessibility and limited awareness compound the problem. India's challenges, including resource scarcity and…
Bharat Biotech partners with Sydney ID to advance vaccine research in infectious diseases
The international agreement aims to build strong sectoral and cross-organisational collaborations to design novel methodologies to…